NES Protein

NES Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">NES (Nestin)</th></tr>
<tr><td><b>Protein Name</b></td><td>Nestin</td></tr>
<tr><td><b>Gene</b></td><td><a href="/genes/nes">NES</a></td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprot/P48681">P48681</a></td></tr>
<tr><td><b>PDB</b></td><td>4O46</td></tr>
<tr><td><b>Molecular Weight</b></td><td>177 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytoplasm, intermediate filament</td></tr>
<tr><td><b>Expression</b></td><td>Neural stem cells, progenitors, CNS</td></tr>
<tr><td><b>Function</b></td><td>Cytoskeletal protein, stem cell marker</td></tr>
</table>
</div>

Overview

Nestin is a class VI intermediate filament protein encoded by the [NES](/genes/nes) gene. Originally discovered as a neural stem cell marker, nestin is expressed in proliferating neural progenitor cells during development and in certain populations of adult stem cells. While primarily a cytoskeletal protein, nestin has been implicated in various neurological conditions including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), brain injury, and brain tumors [1].

Structure and Properties

Protein Architecture

NES Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">NES (Nestin)</th></tr>
<tr><td><b>Protein Name</b></td><td>Nestin</td></tr>
<tr><td><b>Gene</b></td><td><a href="/genes/nes">NES</a></td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprot/P48681">P48681</a></td></tr>
<tr><td><b>PDB</b></td><td>4O46</td></tr>
<tr><td><b>Molecular Weight</b></td><td>177 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytoplasm, intermediate filament</td></tr>
<tr><td><b>Expression</b></td><td>Neural stem cells, progenitors, CNS</td></tr>
<tr><td><b>Function</b></td><td>Cytoskeletal protein, stem cell marker</td></tr>
</table>
</div>

Overview

Nestin is a class VI intermediate filament protein encoded by the [NES](/genes/nes) gene. Originally discovered as a neural stem cell marker, nestin is expressed in proliferating neural progenitor cells during development and in certain populations of adult stem cells. While primarily a cytoskeletal protein, nestin has been implicated in various neurological conditions including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), brain injury, and brain tumors [1].

Structure and Properties

Protein Architecture

Nestin is a large intermediate filament protein:

• N-terminal head domain: Contains phosphorylation sites
• Central α-helical rod domain: Forms coiled-coil structure
• C-terminal tail domain: Multiple phosphorylation sites
• Molecular weight: ~177 kDa

Assembly Properties

Nestin forms intermediate filaments:

• Coassembles with other intermediate filaments
• Forms heteropolymers with vimentin and α-internexin
• Phosphorylation regulates assembly/disassembly
• Dynamic turnover in cells

Expression Patterns

Developmental Expression

During nervous system development, nestin is highly expressed in:

• Neural tube
• Proliferating neural progenitor cells
• Neuroepithelial cells
• Developing [neurons](/entities/neurons) (transiently)

Adult Expression

In adult brains, nestin is expressed in:

• Neural stem cells: In subventricular zone and [hippocampus](/brain-regions/hippocampus)
• Reactive [astrocytes](/entities/astrocytes): Following injury
• Certain neuronal populations: Subset of neurons
• Endothelial cells: In some contexts

Non-Neural Tissues

Nestin is also expressed in:

• Muscle satellite cells
• Hair follicle stem cells
• Pancreatic islet cells
• Endothelial progenitor cells

Functions in the Nervous System

Neural Stem Cell Marker

Nestin serves as a classic neural stem cell marker:

• Identifies proliferating progenitors
• Used to isolate neural stem cells
• Diminishes upon differentiation

Cytoskeletal Support

As an intermediate filament, nestin:

• Provides structural support
• Organizes cytoplasm
• Participates in cell shape determination

Signaling and Scaffolding

Nestin interacts with various proteins:

• p75NTR: Co-receptor for neurotrophins
• MAPK/ERK pathway: Signal transduction
• Cytoskeletal regulators: Rho GTPases

Nestin in Neurodegenerative Diseases

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), nestin has complex roles:

Stem Cell Response

Nestin-expressing cells respond to AD pathology:

• Increased nestin in hippocampus
• Potential attempt at regeneration
• Limited neurogenesis in AD

Amyloid and Tau Interactions

Evidence for nestin-pathology interactions:

• Nestin co-localizes with amyloid plaques
• May influence [tau](/proteins/tau) pathology
• Altered expression in affected regions

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), nestin is relevant to:

Brain Injury and Repair

Nestin is upregulated following:

• Stroke
• Traumatic brain injury
• Spinal cord injury
• Represents a repair response

Therapeutic Implications

Stem Cell Therapy

Nestin-expressing cells are relevant for:

• Cell replacement therapies: Source of progenitors
• In vitro differentiation: Generate neurons/glia
• Gene therapy: Viral targeting

Biomarker Potential

Nestin may serve as:

• Marker of neural injury
• Indicator of regenerative response
• Prognostic biomarker

Regenerative Medicine

Understanding nestin biology supports:

• Enhancing endogenous neurogenesis
• Stem cell transplantation approaches
• Tissue engineering strategies

Summary

Nestin is a class VI intermediate filament protein that serves as a marker for neural stem and progenitor cells. While primarily a cytoskeletal protein, nestin participates in cell signaling, structural organization, and regenerative responses. In neurodegenerative diseases, nestin expression reflects attempted neural repair and may interact with pathological processes. Nestin-positive cells represent potential therapeutic targets for regenerative approaches in Alzheimer's disease, Parkinson's disease, and brain injury.

See Also

• [NES Gene](/genes/nes)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)

External Links

• [GeneCards: NES](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NES)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
• [Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: GPR109A
• [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
• [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4
• [Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication](/hypothesis/h-a4e259e0) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: CHRNA7
• [Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding](/hypothesis/h-8b7727c1) — <span style="color:#81c784;font-weight:600">0.64</span> · Target: CSGA
• [Gut Barrier Permeability-α-Synuclein Axis Modulation](/hypothesis/h-6c83282d) — <span style="color:#ffd54f;font-weight:600">0.60</span> · Target: CLDN1, OCLN, ZO1, MLCK
• [Microbial Metabolite-Mediated α-Synuclein Disaggregation](/hypothesis/h-74777459) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: SNCA, HSPA1A, DNMT1

• [What are the mechanisms by which gut microbiome dysbiosis influences Parkinson&#x27;s disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225149) &#x1f504;
• [What are the mechanisms by which gut microbiome dysbiosis influences Parkinson&#x27;s disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) &#x1f504;
• [Senescent cell clearance as neurodegeneration therapy](/analysis/SDA-2026-04-02-gap-senescent-clearance-neuro) &#x1f504;